🔎 Trials Near Me

Home › Multiple Sclerosis › Kansas

Pag-aaral pangklinika para sa Multiple Sclerosis sa Kansas

9 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Kansas.

Mga Lungsod sa Kansas

Opisyal na teksto ng pag-aaral (English)

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • University of Kansas Clinical Research Center, Fairway
  • HaysMed, Hays
  • University of Kansas Cancer Center, Kansas City
  • at 7 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

  • University of Kansas Medical Center, Kansas City
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07497399

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • The University of Kansas Medical Center, Kansas City
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07002034

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Roeland Park
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06433752

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

  • University of Kansas Medical Center, Kansas City
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06782490

Comparing Telehealth-Delivered CBT-I to Web-Based CBT-I to Enhance Sleep, Reduce Fatigue, and Promote Neuroprotection

  • University of Kansas Medical Center- Sleep, Health and Wellness Laboratory, Kansas City
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06434571

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • University of Kansas Hospital, Kansas City
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07225504

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  • University of Kansas Medical Center, Kansas City
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07477639

Dry Needling in Multiple Sclerosis

  • Mobility and Falls Lab, Kansas City
Nagre-recruit
Edad 18 hanggang 64 · Lahat ng kasarian · Na-update Hun 11, 2025 · NCT06394310

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.